Medline Industries recalls (Class 1 device correction) certain lots of its Craniotomy Kits containing recalled Codman Disposable Perforators 14mm, which may come apart.
FDA will give priority review to a Sprout sNDA to expand the indication for Addyi to treat low sexual desire in post-menopausal women.
Medline Industries recalls (Class 1 device correction) certain lots of its Craniotomy Kits containing recalled Codman Disposable Perforators 14mm, which may come apart.
FDA will give priority review to a Sprout sNDA to expand the indication for Addyi to treat low sexual desire in post-menopausal women.
FDA reportedly is requiring additional safety data from Sarepta Therapeutics before the agency considers supporting use of the company’s Duchenne muscular dystrophy gene therapy Elevidys.
Abivax announces favorable topline results from two pivotal Phase 3 induction trials of its investigational oral therapy obefazimod (ABX464) in moderately to severely active ulcerative colitis patients.
